View Item 

Show simple item record

Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion
dc.contributor.authorLennernäs, Hansen_US
dc.contributor.authorShah, Vinod P.en_US
dc.contributor.authorBarnett, Jeffrey L.en_US
dc.contributor.authorLesko, Lawrence J.en_US
dc.contributor.authorRhie, Julie K.en_US
dc.contributor.authorWelage, Lynda S.en_US
dc.contributor.authorHayashi, Yayoien_US
dc.contributor.authorTakamatsu, Narushien_US
dc.contributor.authorIdkaidek, Nasir M.en_US
dc.contributor.authorLee, Peter I-Deren_US
dc.contributor.authorLiu, Dong-Yueen_US
dc.contributor.authorAmidon, Gordon L.en_US
dc.date.accessioned2006-09-08T19:16:56Z
dc.date.available2006-09-08T19:16:56Z
dc.date.issued1997-09en_US
dc.identifier.citationTakamatsu, Narushi; Welage, Lynda S.; Idkaidek, Nasir M.; Liu, Dong-Yue; Lee, Peter I-Der; Hayashi, Yayoi; Rhie, Julie K.; Lennernäs, Hans; Barnett, Jeffrey L.; Shah, Vinod P.; Lesko, Lawrence; Amidon, Gordon L.; (1997). "Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion." Pharmaceutical Research 14(9): 1127-1132. <http://hdl.handle.net/2027.42/41460>en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.issn0724-8741en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41460
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9327437&dopt=citationen_US
dc.description.abstractPurpose . To determine the human jejunal permeabilities of compounds utilizing different transport mechanisms using a regional perfusion approach and to establish a standard procedure for determining drug permeability class to be used for the establishment of drug product bioequivalence standards.en_US
dc.format.extent561206 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPiroxicamen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherIntestinal Permeabilityen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiopharmaceutic Classification Schemeen_US
dc.subject.otherDrug Absorptionen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherPharmacyen_US
dc.subject.otherPropranololen_US
dc.titleHuman Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Gastroenterology University of Michigan Medical Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherSchool of Pharmacy, Uppsala University, Uppsala, Swedenen_US
dc.contributor.affiliationotherFDA/CBER, 1401 Rockville Pike (HFM-515), Rockville, Maryland, 20852-1448en_US
dc.contributor.affiliationotherNagoya City University, Nagoya, Japanen_US
dc.contributor.affiliationotherFood and Drug Administration, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherJanssen Research Foundation, Titusville, New Jerseyen_US
dc.contributor.affiliationotherFaculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordanen_US
dc.contributor.affiliationotherBiopharmaceutical Computing Center, Beijing Medical University, Beijing, Chinaen_US
dc.contributor.affiliationotherFood and Drug Administration, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherYamanouchi Pharmaceutical Co. Ltd., Shizuoka, Japanen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid9327437en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41460/1/11095_2004_Article_304276.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1012134219095en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_304276.pdf
Size:
548.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.